Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioSyntha Technology

BioSyntha Technology
2012 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of microbial technology intended to produce biofuels from renewable raw materials. The company offers metabolic pathway engineering, fermentation, biocatalysis process development, agrochemical metabolites and natural product development services, enabling businesses to help produce chemicals and fuels from renewable resources, such as non-food crops and waste.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Alternative Energy Equipment
Other Industries
Energy Production
Primary Office
  • Hertfordshire BioPark
  • Broadwater Road
  • Welwyn Garden City AL7 3AX
  • England, United Kingdom

+44 01707 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioSyntha Technology’s full profile, request a free trial.

BioSyntha Technology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 18-May-2015 00.00 Completed Generating Revenue
2. Early Stage VC 14-May-2015 00.000 00.00 00.000 Completed Generating Revenue
1. Seed Round 01-Jan-2014 $490K $490K 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BioSyntha Technology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 2 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 1 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 27,513 $0.015232 $0.15 $0.15 1x $0.15 2.23%
To view this company’s complete Cap Table, request access »

BioSyntha Technology Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 18-May-2015 000000000000000000 Industrial Chemicals
To view this company’s complete investment and acquisition history, request access »

BioSyntha Technology Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Acidophil Venture Capital Minority 000 0000 000000 0
Esperante Ventures Venture Capital Minority 000 0000 000000 0
Midven (Birmingham) Venture Capital Minority 000 0000 000000 0
Oxford Technology Management Venture Capital Minority 000 0000 000000 0
UK Innovation & Science Seed Fund Venture Capital Minority 000 0000 000000 0

BioSyntha Technology Executive Team (3)

Name Title Board
Seat
Contact
Info
Brian Rudd Director, Molecular Biology

2 Former Executives

You’re viewing 1 of 3 executives. Get the full list »